How pharmaceutical companies can structure robust epidemiology evidence packages for health technology assessment bodies in the UK, Germany, France, and beyond.
Back to InsightsUsing Epidemiology Data in HTA Submissions: A Practical Framework
|
Jul 6, 2026
|
5 min read